Cassiopea S.p.A. | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF1.46 |
Market Cap |
CHF442 M |
Shares Outstanding |
10 M |
Public Float |
4.33 M |
Address |
Via Cristoforo Colombo, 1 Milan Milan 20020 Italy |
Employees | - |
Website | http://www.cassiopea.com |
Updated | 07/08/2019 |
Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It engages in developing and commercializing and medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts. The company products include Winlevi, Breezula, CB-06-02 and CB-06-01. |